165 related articles for article (PubMed ID: 29016875)
1. Occupancy of Norepinephrine Transporter by Duloxetine in Human Brains Measured by Positron Emission Tomography with (S,S)-[18F]FMeNER-D2.
Moriguchi S; Takano H; Kimura Y; Nagashima T; Takahata K; Kubota M; Kitamura S; Ishii T; Ichise M; Zhang MR; Shimada H; Mimura M; Meyer JH; Higuchi M; Suhara T
Int J Neuropsychopharmacol; 2017 Dec; 20(12):957-962. PubMed ID: 29016875
[TBL] [Abstract][Full Text] [Related]
2. Norepinephrine transporter occupancy by antidepressant in human brain using positron emission tomography with (S,S)-[18F]FMeNER-D2.
Sekine M; Arakawa R; Ito H; Okumura M; Sasaki T; Takahashi H; Takano H; Okubo Y; Halldin C; Suhara T
Psychopharmacology (Berl); 2010 Jun; 210(3):331-6. PubMed ID: 20309528
[TBL] [Abstract][Full Text] [Related]
3. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2.
Seneca N; Gulyás B; Varrone A; Schou M; Airaksinen A; Tauscher J; Vandenhende F; Kielbasa W; Farde L; Innis RB; Halldin C
Psychopharmacology (Berl); 2006 Sep; 188(1):119-27. PubMed ID: 16896954
[TBL] [Abstract][Full Text] [Related]
4. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of norepinephrine transporter in the human brain using PET with (S,S)-18F-FMeNER-D2.
Arakawa R; Okumura M; Ito H; Seki C; Takahashi H; Takano H; Nakao R; Suzuki K; Okubo Y; Halldin C; Suhara T
J Nucl Med; 2008 Aug; 49(8):1270-6. PubMed ID: 18632811
[TBL] [Abstract][Full Text] [Related]
6. Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [18F]FMeNER-D2.
Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asami Y; Hirano Y; Halldin C; Lundberg J
Int J Neuropsychopharmacol; 2019 Apr; 22(4):278-285. PubMed ID: 30649319
[TBL] [Abstract][Full Text] [Related]
7. PET Quantification of the Norepinephrine Transporter in Human Brain with (
Moriguchi S; Kimura Y; Ichise M; Arakawa R; Takano H; Seki C; Ikoma Y; Takahata K; Nagashima T; Yamada M; Mimura M; Suhara T
J Nucl Med; 2017 Jul; 58(7):1140-1145. PubMed ID: 27980046
[TBL] [Abstract][Full Text] [Related]
8. Serotonin and Norepinephrine Transporter Occupancy of Tramadol in Nonhuman Primate Using Positron Emission Tomography.
Arakawa R; Takano A; Halldin C
Int J Neuropsychopharmacol; 2019 Jan; 22(1):53-56. PubMed ID: 30346535
[TBL] [Abstract][Full Text] [Related]
9. Norepinephrine transporter occupancy by nortriptyline in patients with depression: a positron emission tomography study with (S,S)-[¹⁸F]FMeNER-D₂.
Takano H; Arakawa R; Nogami T; Suzuki M; Nagashima T; Fujiwara H; Kimura Y; Kodaka F; Takahata K; Shimada H; Murakami Y; Tateno A; Yamada M; Ito H; Kawamura K; Zhang MR; Takahashi H; Kato M; Okubo Y; Suhara T
Int J Neuropsychopharmacol; 2014 Apr; 17(4):553-60. PubMed ID: 24345533
[TBL] [Abstract][Full Text] [Related]
10. Imaging the norepinephrine transporter with positron emission tomography: initial human studies with (S,S)-[18F]FMeNER-D2.
Takano A; Gulyás B; Varrone A; Karlsson P; Schou M; Airaksinen AJ; Vandenhende F; Tauscher J; Halldin C
Eur J Nucl Med Mol Imaging; 2008 Jan; 35(1):153-7. PubMed ID: 17909794
[TBL] [Abstract][Full Text] [Related]
11. PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain.
Schou M; Halldin C; Sóvágó J; Pike VW; Hall H; Gulyás B; Mozley PD; Dobson D; Shchukin E; Innis RB; Farde L
Synapse; 2004 Aug; 53(2):57-67. PubMed ID: 15170818
[TBL] [Abstract][Full Text] [Related]
12. Norepinephrine transporter occupancy in the human brain after oral administration of quetiapine XR.
Nyberg S; Jucaite A; Takano A; Kågedal M; Cselényi Z; Halldin C; Farde L
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2235-44. PubMed ID: 23809226
[TBL] [Abstract][Full Text] [Related]
13. Prediction of human serotonin and norepinephrine transporter occupancy of duloxetine by pharmacokinetic/pharmacodynamic modeling in the rat.
Bourdet DL; Tsuruda PR; Obedencio GP; Smith JA
J Pharmacol Exp Ther; 2012 Apr; 341(1):137-45. PubMed ID: 22235148
[TBL] [Abstract][Full Text] [Related]
14. Saturated norepinephrine transporter occupancy by atomoxetine relevant to clinical doses: a rhesus monkey study with (S,S)-[(18)F]FMeNER-D (2).
Takano A; Gulyás B; Varrone A; Maguire RP; Halldin C
Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1308-14. PubMed ID: 19300997
[TBL] [Abstract][Full Text] [Related]
15. [18F]FMeNER-D2: reliable fully-automated synthesis for visualization of the norepinephrine transporter.
Rami-Mark C; Zhang MR; Mitterhauser M; Lanzenberger R; Hacker M; Wadsak W
Nucl Med Biol; 2013 Nov; 40(8):1049-54. PubMed ID: 24100201
[TBL] [Abstract][Full Text] [Related]
16. Relationship between serotonin transporter occupancies and analgesic effects of AS1069562, the (+)-isomer of indeloxazine, and duloxetine in reserpine-induced myalgia rats.
Murai N; Fushiki H; Honda S; Murakami Y; Iwashita A; Irie M; Tamura S; Nagakura Y; Aoki T
Neuroscience; 2015 Mar; 289():262-9. PubMed ID: 25595980
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[18F]FMeNER-D2: a human whole-body PET study.
Takano A; Halldin C; Varrone A; Karlsson P; Sjöholm N; Stubbs JB; Schou M; Airaksinen AJ; Tauscher J; Gulyás B
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):630-6. PubMed ID: 18000665
[TBL] [Abstract][Full Text] [Related]
18. Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2.
Takano A; Varrone A; Gulyás B; Karlsson P; Tauscher J; Halldin C
Neuroimage; 2008 Aug; 42(2):474-82. PubMed ID: 18617423
[TBL] [Abstract][Full Text] [Related]
19. A dose-finding study of duloxetine based on serotonin transporter occupancy.
Takano A; Suzuki K; Kosaka J; Ota M; Nozaki S; Ikoma Y; Tanada S; Suhara T
Psychopharmacology (Berl); 2006 Apr; 185(3):395-9. PubMed ID: 16506079
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine.
Ding YS; Lin KS; Logan J; Benveniste H; Carter P
J Neurochem; 2005 Jul; 94(2):337-51. PubMed ID: 15998285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
